CTLA-4 is a second receptor for the B cell activation antigen B7.
Peter S. Linsley(Rosetta Stone (United States)), J A Ledbetter(Bristol-Myers Squibb (Germany))
Cited by 1,688
Related Papers
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
|Immunity|1994|971
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome
|Cell|1993|824
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
|RNA|2006|785
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|708
Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
|The Journal of Experimental Medicine|1994|246